SlideShare a Scribd company logo
1 of 6
Download to read offline
Ansewr1
Principal Amount Term Due Date Interest Rate Interest Maturity Value
1) Aug 1 24,000 1 year 1-Aug-15 17% 4,080.00 28,080.00
2) Nov 30 18,000 6 months 30-May-15 6% 540.00 18,540.00
3) Dec 19 12,000 30 days 18-Jan-15 12% 118.36 12,118.36
Total 4,738.36 58,738
Answer 2
Date
Particulars
Debit
Credit
2014
Aug.1
Dr. Investment in 17% notes Receivable A/c
Cr. To Cash or Loan A/c ( if loan converted in Notes)
$24000
$24000
Nov.2
Dr. Investment in 6% notes Receivable A/c Dr
Cr. To Cash
$18000
$18,000
Dec .3
Dr. Investment in 12% notes Receivable A/c Dr
Cr. Cash A/c
$12,000
$12,000
Dec31
Dr. Interest Receivable (Balance Sheet)
Cr. Interest A/c
(4080*6/12+540*1/6+118.36*12/30days)204090
$2177
$2177
Anwer 3
Date
Particulars
Debit $
Cr. $
2015
Aug1
Cash A/c Dr
To Investment in 17% notes Receivable A/c
To Interest Receivable A/c
To interest A/c
28,080
24,000
2040
2040
May30
Cash A/c Dr
To Investment in 6% notes Receivable A/c
To Interest Receivable A/c
To interest A/c
18,540
18,000
90
450
Jan 18
Cash A/c Dr
To Investment in 12% notes Receivable A/c
To Interest Receivable A/c
To interest A/c
12,118
12,000
70
47
Date
Particulars
Debit
Credit
2014
Aug.1
Dr. Investment in 17% notes Receivable A/c
Cr. To Cash or Loan A/c ( if loan converted in Notes)
$24000
$24000
Nov.2
Dr. Investment in 6% notes Receivable A/c Dr
Cr. To Cash
$18000
$18,000
Dec .3
Dr. Investment in 12% notes Receivable A/c Dr
Cr. Cash A/c
$12,000
$12,000
Dec31
Dr. Interest Receivable (Balance Sheet)
Cr. Interest A/c
(4080*6/12+540*1/6+118.36*12/30days)204090
$2177
$2177
Solution
Ansewr1
Principal Amount Term Due Date Interest Rate Interest Maturity Value
1) Aug 1 24,000 1 year 1-Aug-15 17% 4,080.00 28,080.00
2) Nov 30 18,000 6 months 30-May-15 6% 540.00 18,540.00
3) Dec 19 12,000 30 days 18-Jan-15 12% 118.36 12,118.36
Total 4,738.36 58,738
Answer 2
Date
Particulars
Debit
Credit
2014
Aug.1
Dr. Investment in 17% notes Receivable A/c
Cr. To Cash or Loan A/c ( if loan converted in Notes)
$24000
$24000
Nov.2
Dr. Investment in 6% notes Receivable A/c Dr
Cr. To Cash
$18000
$18,000
Dec .3
Dr. Investment in 12% notes Receivable A/c Dr
Cr. Cash A/c
$12,000
$12,000
Dec31
Dr. Interest Receivable (Balance Sheet)
Cr. Interest A/c
(4080*6/12+540*1/6+118.36*12/30days)204090
$2177
$2177
Anwer 3
Date
Particulars
Debit $
Cr. $
2015
Aug1
Cash A/c Dr
To Investment in 17% notes Receivable A/c
To Interest Receivable A/c
To interest A/c
28,080
24,000
2040
2040
May30
Cash A/c Dr
To Investment in 6% notes Receivable A/c
To Interest Receivable A/c
To interest A/c
18,540
18,000
90
450
Jan 18
Cash A/c Dr
To Investment in 12% notes Receivable A/c
To Interest Receivable A/c
To interest A/c
12,118
12,000
70
47
Date
Particulars
Debit
Credit
2014
Aug.1
Dr. Investment in 17% notes Receivable A/c
Cr. To Cash or Loan A/c ( if loan converted in Notes)
$24000
$24000
Nov.2
Dr. Investment in 6% notes Receivable A/c Dr
Cr. To Cash
$18000
$18,000
Dec .3
Dr. Investment in 12% notes Receivable A/c Dr
Cr. Cash A/c
$12,000
$12,000
Dec31
Dr. Interest Receivable (Balance Sheet)
Cr. Interest A/c
(4080*6/12+540*1/6+118.36*12/30days)204090
$2177
$2177

More Related Content

More from aparnawatchcompany

Not all analytes re non-polar hydrophobic substan.pdf
                     Not all analytes re non-polar hydrophobic substan.pdf                     Not all analytes re non-polar hydrophobic substan.pdf
Not all analytes re non-polar hydrophobic substan.pdf
aparnawatchcompany
 
Off-balance sheet problems have recurred throughout history, with .pdf
    Off-balance sheet problems have recurred throughout history, with .pdf    Off-balance sheet problems have recurred throughout history, with .pdf
Off-balance sheet problems have recurred throughout history, with .pdf
aparnawatchcompany
 
Well the only difference between the two structur.pdf
                     Well the only difference between the two structur.pdf                     Well the only difference between the two structur.pdf
Well the only difference between the two structur.pdf
aparnawatchcompany
 
The short answer is no. SN2 reactions are governed by several factor.pdf
The short answer is no. SN2 reactions are governed by several factor.pdfThe short answer is no. SN2 reactions are governed by several factor.pdf
The short answer is no. SN2 reactions are governed by several factor.pdf
aparnawatchcompany
 
Technology has taking milestone forwarding steps and they are using .pdf
Technology has taking milestone forwarding steps and they are using .pdfTechnology has taking milestone forwarding steps and they are using .pdf
Technology has taking milestone forwarding steps and they are using .pdf
aparnawatchcompany
 
Plantaris muscleThe plantaris is one of the superficial muscles of.pdf
Plantaris muscleThe plantaris is one of the superficial muscles of.pdfPlantaris muscleThe plantaris is one of the superficial muscles of.pdf
Plantaris muscleThe plantaris is one of the superficial muscles of.pdf
aparnawatchcompany
 
Non-coded RNA are small RNA molecule that cannot be translated by ho.pdf
Non-coded RNA are small RNA molecule that cannot be translated by ho.pdfNon-coded RNA are small RNA molecule that cannot be translated by ho.pdf
Non-coded RNA are small RNA molecule that cannot be translated by ho.pdf
aparnawatchcompany
 

More from aparnawatchcompany (20)

I am sorry . image is too small. the expression is not clearly.pdf
 I am sorry . image is too small. the expression is not clearly.pdf I am sorry . image is too small. the expression is not clearly.pdf
I am sorry . image is too small. the expression is not clearly.pdf
 
the molar ratio of Na2S2O3 CL2 = 1 4 moles of.pdf
                     the molar ratio of Na2S2O3  CL2 = 1  4 moles of.pdf                     the molar ratio of Na2S2O3  CL2 = 1  4 moles of.pdf
the molar ratio of Na2S2O3 CL2 = 1 4 moles of.pdf
 
object persistence formats Sequential access optimized for operat.pdf
  object persistence formats   Sequential access  optimized for operat.pdf  object persistence formats   Sequential access  optimized for operat.pdf
object persistence formats Sequential access optimized for operat.pdf
 
The answer is b.) 4 Distribution coefficient = .pdf
                     The answer is b.) 4  Distribution coefficient = .pdf                     The answer is b.) 4  Distribution coefficient = .pdf
The answer is b.) 4 Distribution coefficient = .pdf
 
Not all analytes re non-polar hydrophobic substan.pdf
                     Not all analytes re non-polar hydrophobic substan.pdf                     Not all analytes re non-polar hydrophobic substan.pdf
Not all analytes re non-polar hydrophobic substan.pdf
 
Off-balance sheet problems have recurred throughout history, with .pdf
    Off-balance sheet problems have recurred throughout history, with .pdf    Off-balance sheet problems have recurred throughout history, with .pdf
Off-balance sheet problems have recurred throughout history, with .pdf
 
Well the only difference between the two structur.pdf
                     Well the only difference between the two structur.pdf                     Well the only difference between the two structur.pdf
Well the only difference between the two structur.pdf
 
Compunds composed of hydrogen and either fluorine.pdf
                     Compunds composed of hydrogen and either fluorine.pdf                     Compunds composed of hydrogen and either fluorine.pdf
Compunds composed of hydrogen and either fluorine.pdf
 
The Seliwanoffs Test is a test for ketoses. Of .pdf
                     The Seliwanoffs Test is a test for ketoses. Of .pdf                     The Seliwanoffs Test is a test for ketoses. Of .pdf
The Seliwanoffs Test is a test for ketoses. Of .pdf
 
The short answer is no. SN2 reactions are governed by several factor.pdf
The short answer is no. SN2 reactions are governed by several factor.pdfThe short answer is no. SN2 reactions are governed by several factor.pdf
The short answer is no. SN2 reactions are governed by several factor.pdf
 
Technology has taking milestone forwarding steps and they are using .pdf
Technology has taking milestone forwarding steps and they are using .pdfTechnology has taking milestone forwarding steps and they are using .pdf
Technology has taking milestone forwarding steps and they are using .pdf
 
Solution(a)Basic DefLet R be a binary relation on a set A.R i.pdf
Solution(a)Basic DefLet R be a binary relation on a set A.R i.pdfSolution(a)Basic DefLet R be a binary relation on a set A.R i.pdf
Solution(a)Basic DefLet R be a binary relation on a set A.R i.pdf
 
Section 4 we describe how theSolutionSection 4 we describe how.pdf
Section 4 we describe how theSolutionSection 4 we describe how.pdfSection 4 we describe how theSolutionSection 4 we describe how.pdf
Section 4 we describe how theSolutionSection 4 we describe how.pdf
 
probability= 10100=0.1Simple.Solutionprobability= 10100=0..pdf
probability= 10100=0.1Simple.Solutionprobability= 10100=0..pdfprobability= 10100=0.1Simple.Solutionprobability= 10100=0..pdf
probability= 10100=0.1Simple.Solutionprobability= 10100=0..pdf
 
Plantaris muscleThe plantaris is one of the superficial muscles of.pdf
Plantaris muscleThe plantaris is one of the superficial muscles of.pdfPlantaris muscleThe plantaris is one of the superficial muscles of.pdf
Plantaris muscleThe plantaris is one of the superficial muscles of.pdf
 
I think... Highest energy = most polarized = h.pdf
                     I think...  Highest energy = most polarized = h.pdf                     I think...  Highest energy = most polarized = h.pdf
I think... Highest energy = most polarized = h.pdf
 
P( 0 Z 1.5 )= P(Z1.5) - P(Z0)= 0.9332 - 0.5 (from table)= .pdf
P( 0 Z 1.5 )= P(Z1.5) - P(Z0)= 0.9332 - 0.5 (from table)= .pdfP( 0 Z 1.5 )= P(Z1.5) - P(Z0)= 0.9332 - 0.5 (from table)= .pdf
P( 0 Z 1.5 )= P(Z1.5) - P(Z0)= 0.9332 - 0.5 (from table)= .pdf
 
Non-coded RNA are small RNA molecule that cannot be translated by ho.pdf
Non-coded RNA are small RNA molecule that cannot be translated by ho.pdfNon-coded RNA are small RNA molecule that cannot be translated by ho.pdf
Non-coded RNA are small RNA molecule that cannot be translated by ho.pdf
 
Option b is Settlement risk The Nonschedule L off-balance-sheet ri.pdf
Option b is Settlement risk The Nonschedule L off-balance-sheet ri.pdfOption b is Settlement risk The Nonschedule L off-balance-sheet ri.pdf
Option b is Settlement risk The Nonschedule L off-balance-sheet ri.pdf
 
mSolutionm.pdf
mSolutionm.pdfmSolutionm.pdf
mSolutionm.pdf
 

Recently uploaded

Transparency, Recognition and the role of eSealing - Ildiko Mazar and Koen No...
Transparency, Recognition and the role of eSealing - Ildiko Mazar and Koen No...Transparency, Recognition and the role of eSealing - Ildiko Mazar and Koen No...
Transparency, Recognition and the role of eSealing - Ildiko Mazar and Koen No...
EADTU
 

Recently uploaded (20)

MOOD STABLIZERS DRUGS.pptx
MOOD     STABLIZERS           DRUGS.pptxMOOD     STABLIZERS           DRUGS.pptx
MOOD STABLIZERS DRUGS.pptx
 
Climbers and Creepers used in landscaping
Climbers and Creepers used in landscapingClimbers and Creepers used in landscaping
Climbers and Creepers used in landscaping
 
Sternal Fractures & Dislocations - EMGuidewire Radiology Reading Room
Sternal Fractures & Dislocations - EMGuidewire Radiology Reading RoomSternal Fractures & Dislocations - EMGuidewire Radiology Reading Room
Sternal Fractures & Dislocations - EMGuidewire Radiology Reading Room
 
When Quality Assurance Meets Innovation in Higher Education - Report launch w...
When Quality Assurance Meets Innovation in Higher Education - Report launch w...When Quality Assurance Meets Innovation in Higher Education - Report launch w...
When Quality Assurance Meets Innovation in Higher Education - Report launch w...
 
demyelinated disorder: multiple sclerosis.pptx
demyelinated disorder: multiple sclerosis.pptxdemyelinated disorder: multiple sclerosis.pptx
demyelinated disorder: multiple sclerosis.pptx
 
ANTI PARKISON DRUGS.pptx
ANTI         PARKISON          DRUGS.pptxANTI         PARKISON          DRUGS.pptx
ANTI PARKISON DRUGS.pptx
 
Observing-Correct-Grammar-in-Making-Definitions.pptx
Observing-Correct-Grammar-in-Making-Definitions.pptxObserving-Correct-Grammar-in-Making-Definitions.pptx
Observing-Correct-Grammar-in-Making-Definitions.pptx
 
ĐỀ THAM KHẢO KÌ THI TUYỂN SINH VÀO LỚP 10 MÔN TIẾNG ANH FORM 50 CÂU TRẮC NGHI...
ĐỀ THAM KHẢO KÌ THI TUYỂN SINH VÀO LỚP 10 MÔN TIẾNG ANH FORM 50 CÂU TRẮC NGHI...ĐỀ THAM KHẢO KÌ THI TUYỂN SINH VÀO LỚP 10 MÔN TIẾNG ANH FORM 50 CÂU TRẮC NGHI...
ĐỀ THAM KHẢO KÌ THI TUYỂN SINH VÀO LỚP 10 MÔN TIẾNG ANH FORM 50 CÂU TRẮC NGHI...
 
Transparency, Recognition and the role of eSealing - Ildiko Mazar and Koen No...
Transparency, Recognition and the role of eSealing - Ildiko Mazar and Koen No...Transparency, Recognition and the role of eSealing - Ildiko Mazar and Koen No...
Transparency, Recognition and the role of eSealing - Ildiko Mazar and Koen No...
 
Đề tieng anh thpt 2024 danh cho cac ban hoc sinh
Đề tieng anh thpt 2024 danh cho cac ban hoc sinhĐề tieng anh thpt 2024 danh cho cac ban hoc sinh
Đề tieng anh thpt 2024 danh cho cac ban hoc sinh
 
Major project report on Tata Motors and its marketing strategies
Major project report on Tata Motors and its marketing strategiesMajor project report on Tata Motors and its marketing strategies
Major project report on Tata Motors and its marketing strategies
 
Improved Approval Flow in Odoo 17 Studio App
Improved Approval Flow in Odoo 17 Studio AppImproved Approval Flow in Odoo 17 Studio App
Improved Approval Flow in Odoo 17 Studio App
 
diagnosting testing bsc 2nd sem.pptx....
diagnosting testing bsc 2nd sem.pptx....diagnosting testing bsc 2nd sem.pptx....
diagnosting testing bsc 2nd sem.pptx....
 
How to Manage Website in Odoo 17 Studio App.pptx
How to Manage Website in Odoo 17 Studio App.pptxHow to Manage Website in Odoo 17 Studio App.pptx
How to Manage Website in Odoo 17 Studio App.pptx
 
How To Create Editable Tree View in Odoo 17
How To Create Editable Tree View in Odoo 17How To Create Editable Tree View in Odoo 17
How To Create Editable Tree View in Odoo 17
 
Including Mental Health Support in Project Delivery, 14 May.pdf
Including Mental Health Support in Project Delivery, 14 May.pdfIncluding Mental Health Support in Project Delivery, 14 May.pdf
Including Mental Health Support in Project Delivery, 14 May.pdf
 
Andreas Schleicher presents at the launch of What does child empowerment mean...
Andreas Schleicher presents at the launch of What does child empowerment mean...Andreas Schleicher presents at the launch of What does child empowerment mean...
Andreas Schleicher presents at the launch of What does child empowerment mean...
 
Scopus Indexed Journals 2024 - ISCOPUS Publications
Scopus Indexed Journals 2024 - ISCOPUS PublicationsScopus Indexed Journals 2024 - ISCOPUS Publications
Scopus Indexed Journals 2024 - ISCOPUS Publications
 
8 Tips for Effective Working Capital Management
8 Tips for Effective Working Capital Management8 Tips for Effective Working Capital Management
8 Tips for Effective Working Capital Management
 
Graduate Outcomes Presentation Slides - English (v3).pptx
Graduate Outcomes Presentation Slides - English (v3).pptxGraduate Outcomes Presentation Slides - English (v3).pptx
Graduate Outcomes Presentation Slides - English (v3).pptx
 

Ansewr1Principal Amount Term Due Date Interest Rate Interest Matur.pdf

  • 1. Ansewr1 Principal Amount Term Due Date Interest Rate Interest Maturity Value 1) Aug 1 24,000 1 year 1-Aug-15 17% 4,080.00 28,080.00 2) Nov 30 18,000 6 months 30-May-15 6% 540.00 18,540.00 3) Dec 19 12,000 30 days 18-Jan-15 12% 118.36 12,118.36 Total 4,738.36 58,738 Answer 2 Date Particulars Debit Credit 2014 Aug.1 Dr. Investment in 17% notes Receivable A/c Cr. To Cash or Loan A/c ( if loan converted in Notes) $24000 $24000 Nov.2 Dr. Investment in 6% notes Receivable A/c Dr Cr. To Cash $18000 $18,000 Dec .3 Dr. Investment in 12% notes Receivable A/c Dr Cr. Cash A/c $12,000 $12,000 Dec31 Dr. Interest Receivable (Balance Sheet) Cr. Interest A/c (4080*6/12+540*1/6+118.36*12/30days)204090 $2177 $2177 Anwer 3
  • 2. Date Particulars Debit $ Cr. $ 2015 Aug1 Cash A/c Dr To Investment in 17% notes Receivable A/c To Interest Receivable A/c To interest A/c 28,080 24,000 2040 2040 May30 Cash A/c Dr To Investment in 6% notes Receivable A/c To Interest Receivable A/c To interest A/c 18,540 18,000 90 450 Jan 18 Cash A/c Dr To Investment in 12% notes Receivable A/c To Interest Receivable A/c To interest A/c 12,118 12,000 70 47 Date Particulars Debit Credit
  • 3. 2014 Aug.1 Dr. Investment in 17% notes Receivable A/c Cr. To Cash or Loan A/c ( if loan converted in Notes) $24000 $24000 Nov.2 Dr. Investment in 6% notes Receivable A/c Dr Cr. To Cash $18000 $18,000 Dec .3 Dr. Investment in 12% notes Receivable A/c Dr Cr. Cash A/c $12,000 $12,000 Dec31 Dr. Interest Receivable (Balance Sheet) Cr. Interest A/c (4080*6/12+540*1/6+118.36*12/30days)204090 $2177 $2177 Solution Ansewr1 Principal Amount Term Due Date Interest Rate Interest Maturity Value 1) Aug 1 24,000 1 year 1-Aug-15 17% 4,080.00 28,080.00 2) Nov 30 18,000 6 months 30-May-15 6% 540.00 18,540.00 3) Dec 19 12,000 30 days 18-Jan-15 12% 118.36 12,118.36 Total 4,738.36 58,738 Answer 2 Date Particulars Debit
  • 4. Credit 2014 Aug.1 Dr. Investment in 17% notes Receivable A/c Cr. To Cash or Loan A/c ( if loan converted in Notes) $24000 $24000 Nov.2 Dr. Investment in 6% notes Receivable A/c Dr Cr. To Cash $18000 $18,000 Dec .3 Dr. Investment in 12% notes Receivable A/c Dr Cr. Cash A/c $12,000 $12,000 Dec31 Dr. Interest Receivable (Balance Sheet) Cr. Interest A/c (4080*6/12+540*1/6+118.36*12/30days)204090 $2177 $2177 Anwer 3 Date Particulars Debit $ Cr. $ 2015 Aug1 Cash A/c Dr To Investment in 17% notes Receivable A/c To Interest Receivable A/c To interest A/c 28,080 24,000
  • 5. 2040 2040 May30 Cash A/c Dr To Investment in 6% notes Receivable A/c To Interest Receivable A/c To interest A/c 18,540 18,000 90 450 Jan 18 Cash A/c Dr To Investment in 12% notes Receivable A/c To Interest Receivable A/c To interest A/c 12,118 12,000 70 47 Date Particulars Debit Credit 2014 Aug.1 Dr. Investment in 17% notes Receivable A/c Cr. To Cash or Loan A/c ( if loan converted in Notes) $24000 $24000 Nov.2 Dr. Investment in 6% notes Receivable A/c Dr Cr. To Cash $18000 $18,000 Dec .3
  • 6. Dr. Investment in 12% notes Receivable A/c Dr Cr. Cash A/c $12,000 $12,000 Dec31 Dr. Interest Receivable (Balance Sheet) Cr. Interest A/c (4080*6/12+540*1/6+118.36*12/30days)204090 $2177 $2177